Could the analysis of the cost of postradiation side effects be a worthwhile mean to help the improvement of radiation therapy?;L'evaluation du cout des complications peut-elle contribuer la poursuite du developpement de la radiotherapie?

Cancer/Radiotherapie

Volumn 1, Issue 6, 1997, Pages 836-847

  Daly Schveitzer, N ^a  

^a INSTITUT CLAUDIUS REGAUD   (France)

Author keywords

Complications; Cost; LENT SOMA; Radiation therapy

Indexed keywords

CANCER RADIOTHERAPY; COST BENEFIT ANALYSIS; HUMAN; MEDICAL DECISION MAKING; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; REVIEW; COST; ECONOMICS; EVALUATION; HEALTH CARE COST; MORTALITY; NEOPLASM; RADIOTHERAPY; TREATMENT FAILURE;

COSTS AND COST ANALYSIS; EVALUATION STUDIES; HEALTH CARE COSTS; HUMANS; NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY; TREATMENT FAILURE;

EID: 0031426397     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(97)82965-4     Document Type: Article

References (71)

1. Al-Mefty O, Kersh JE, Routh A, Smith RR. The long-term side effects of radiation therapy for benign brain tumors in adults. J Neurosurg 1990;73:502-12
2. Amdur RJ, Kalbaugh KJ, Ewald LM, Parsons JT, Mendenhall WM, Bova FJ et al. Radiation therapy for skin cancer near the eye: kilovoltage x-rays versus electrons. Int J Radiat Oncol Biol Phys 1992;23:769-79
3. Auchter RM, Lamond JP, Alexander E, Buatti JM, Chappell R, Friedman WA et al. A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. Int J Radiat Oncol Biol Phys 1996;35:27-35
4. Badcock PC. The cost effectiveness of CT-assisted radiotherapy planning. Strahlentherapie 1984;160:427-30
5. Barton MB, Gebski V, Manderson C, Langlands AO. Radiation therapy: are we getting value for money? Clin Oncol 1995;7:287-92
6. Bastin K, Buchler D, Stitt J, Shanahan T, Pola Y, Paliwa) B et al. Resource utilization. High dose rate versus low dose rate brachytherapy for gynecologic cancer. Am J Clin Oncol 1993; 16:256-63
7. Beard CJ, Propert KJ, Rieker PP, Clark JA, Kaplan I, Kantoff PW et al. Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes study. J Clin Oncol 1997;15:223-9
8. Beck JR, Pauker SG. The Markov process in medical prognosis. Med Decis Making 1983;3:419-58
9. Becker G, Schlegel W, Major J, Grote EH, Bamberg M. Stereotactic convergent beam radiosurgery versus stereotactic conformation beam radiotherapy. Acta Neurochir Suppl 1995; 63:44-51
10. Becker G, Kortmann R, Kaulich TW, Duffner F, Bamberg M. Gamma knife versus stereotactic linear accelerator. Utilization, clinical results and cost-benefit relations. Radiologe 1996; 36:345-53
11. Bernier J, Peters LJ. Cost containment in health care: a transatlantic perspective on radiotherapy. Int J Radiat Oncol Biol Phys 1994;29:1189-90
12. Blasko JC, Ragde H, Luse RW, Sylvester JE, Cavanagh W, Grimm PD. Should brachytherapy be considered a therapeutic option in localized prostate cancer? Urol Clin North Am 1996; 23:633-50
13. Brada M, Laing R. Radiosurgery/stereotactic external beam radiotherapy for malignant brain tumours: the Royal Marsden Hospital experience. Recent Results Cancer Res 1994; 135:91-104
14. Brown ML. The national economic burden of cancer: an update. J Natl Cancer Inst 1990;82:18111-4
15. Caffo O, Fellin G, Graffer U, Luciani L. Assessment of quality of life after radical radiotherapy for prostate cancer. Br J Urol 1996;78:557-63
16. Chazel H, Daly-Schveitzer N, Delande G, Dubois JB, Lapeyre-Mestre M, Negre M. Stratégies thérapeutiques et coût du traitement du cancer du sein: évolutions 1975-1985. J Éco Méd 1993;11:123-4
17. Cohen ME, Duffner PK. Optic pathway tumors. Neurol Clin 1991 May;9:467-77
18. Daly-Schveitzer N, Delmas S, Bonhomme C, Verdier A. Le coût de la radiothérapie. Évaluation du coût réel des traitements réalisés dans un service de radiothérapie d'une centre de lutte contre le cancer. Bull Cancer/Radiother 1995;82:370-8
19. Daly-Schveitzer N, Delmas S, Bonhomme C, Verdier A. Étude comparative des coûts réels des actes de radiothérapie et de leur valorisation par lettre clé. Analyse réalisée dans le Département de radiothérapie d'un Centre de lutte contre le cancer. Bull Cancer/Radiother 1997;4:314-22
20. Das IJ, Kase KR. Higher energy: is it necessary, is it worth the cost for radiation oncology? Med Phys 1992;19:917-25
21. Davies E, Clarke C, Hopkins A. Malignant cerebral glioma. I. Survival, disability, and morbidity after radiotherapy. BMJ 1996;313:1507-12
22. Detsky AS, Naglie IG. A clinician's guide to cost-effectiveness analysis. Ann Intern Med 1990;113:147-54
23. Dewit L, Ang KK, Van der Schueren E. Acute side effects and late complications after radiotherapy of localized carcinoma of the prostate. Cancer Treat Rev 1983;10:79-89
24. Drummond MF. The economic evaluation of cancer treatments and programmes. Eur J Cancer 1991;27:1191-6
25. Engenhart R, Kimmig BN, Hö̈ver KH, Wowra B, Sturm V, Van Kaick G et al. Stereotactic single high dose radiation therapy of benign intracranial meningiomas. Int J Radiat Oncol Biol Phys 1990;19:1021-6
26. Fineberg HV, Hiatt HH. Evaluation of medical practices. The case for technology assessment. N Engl J Med 1979;301: 1086-91
27. Finkler SA. The distinction between cost and charges. Ann Intern Med 1982;96:102-9
28. Flickinger JC, Lunsford LD, Somaza S, Kondziolka D. Radiosurgery: its role in brain metastasis management. Stereotactic radiosurgery is effective in controlling brain metastasis at presentation and those that recur after radiotherapy. It is the treatment of choice for most patients with small solitary brain metastasis by virtue of its low morbidity, high-effectiveness, and cost. Neurosurg Clin N Am 1996;7:497-504
29. Freire J, Longton WA, Miyamoto CT, Brady LW, Augsburger J, Brown G et al. External radiotherapy in macular degeneration: technique and preliminary subjective response. Int J Radiat Oncol Biol Phys 1996;36:857-60
30. Friedman WA, Bova FJ, Spiegelmann R. Linear accelerator radiosurgery at the University of Florida. Neurosurg Clin N Am 1992;3:141-66
31. Gademann G, Schlegel W, Debus J, Schad L, Bortfeld T, Hover KH et al. Fractionated stereotactically guided radiotherapy of head and neck tumors: a report on clinical use of a new system in 195 cases. Radiother Oncol 1993;29:205-13
32. Glazebrook GA. Radiation therapy: a long term cost benefit analysis in a North American region. Clin Oncol 1992;4:302-5
33. Goddard MK, Hutton J. What is the cost of radiotherapy? Eur J Radiol 1991;13:76-9
34. Goddard M, Drummond M. The economic evaluation of cancer treatments and programmes. Eur J Cancer 1991;27:1191-6
35. Hanks GE. Treatment of early stage prostate cancer: radiotherapy. Important Adv Oncol 1994;12:225-39
36. Hanks GE, Dunlap K. A comparison of the cost of various treatment methods for early cancer of the prostate. Int J Radiat Oncol Biol Phys 1986;12:1879-81
37. Hayman J, Weeks J, Mauch P. Economic analyses in health care: an introduction to the methodology with an emphasis on radiation therapy. Int J Radiat Oncol Biol Phys 1996;35: 827-41
38. Herbert SH, Curran WJ Jr, Solin LJ, Stafford PM, Lanciano RM, Hanks GE. Decreasing gastrointestinal morbidity with the use of small bowel contrast during treatment planning for pelvic irradiation. Int J Radiat Oncol Biol Phys 1991;20:835-42
39. Hettenbach A, Adler M, Noack EJ, Wiest W. Cost-benefit studies of two equivalent forms of therapy in cervical cancer in the pretherapeutic T 1b stage. Geburtsh Frauenheilkd 1985;45:294-8
40. Hillner BE, Smith TJ. Efficacy and cost-effectiveness of adjuvant chemotherapy in women with node-negative breast cancer. A decision analysis model. N Engl J Med 1991;324:160-8
41. Janjan N, Yasko AW, Reece GP, Miller MJ, Murray JA, Ross MI et al. Comparison of charges related to radiotherapy for softtissue sarcomas treated by preoperative external-beam irradiation versus interstitial implantation. Ann Surg Oncol 1994;1:415-21
42. Kesteloot K, Dutreix A, Van der Schueren E. Quality assurance procedures in radiotherapy: economic criteria to support decision making. Int J Technol Assess Health Care 1993; 9:274-85
43. Khoo VS, Dearnaley DP, Finnigan DJ, Padhani A, Tanner SF, Leach MO. Magnetic resonance imaging (MRI): considerations and applications in radiotherapy treatment planning. Radiother Oncol 1997;42:1-15
44. Lai PP, Perez CA, Shapiro SJ, Lockett MA. Carcinoma of the prostate stage B and C: lack of influence of duration of radiotherapy on tumor control and treatment morbidity. Int J Radiat Oncol Biol Phys 1990;19:561-8
45. Lam KS, Wang C, Choi P, Ma JT, Yeung RT. Long-term effects of megavoltage radiotherapy in acromegaly. Aust N Z J Med 1989;19:202-6
46. Lapeyre-Mestre M, Daly-Schveitzer N, Boussin G, Delande G. Évaluation coût/efficacité de la prise en charge du cancer du sein. Analyse comparative 1975-1985 dans un centre de lutte contre le cancer. Rev Épidémiol Santé Publique 1993;41: 397-406
47. Lievens Y, Vanuytsel L, Rijnders A, Van Poppel H, Van der Schueren E. The time course of development of late side effects after irradiation of the prostate with multiple fractions per day. Radiother Oncol 1996;40:147-52
48. Ling CC, Fuks Z. Conformal radiation treatment: a critical appraisal. Eur J Cancer 1995;31:799-803
49. Ljung G, Häggman M, Hansson H, Holmberg L, Nilsson S. Adverse effects after radical external beam radiotherapy of localized prostatic adenocarcinoma using two-dimensional dose-planning and a limited field technique. Acta Oncol 1996;35:445-50
50. Merkle K, Lessel A, Hüttner J. Quality assurance in radiotherapy. A clinical view-point. Radiobiol Radiother 1990;31:19-23
51. Norum J, Angelsen V, Wist E, Olsen JA. Treatment costs in Hodgkin's disease: a cost-utility analysis. Eur J Cancer 1996; 32A:1510-7
52. Penar PL, Wilson JT. Cost and survival analysis of metastatic cerebral tumors treated by resection and radiation. Neurosurgery 1994;34:888-94
53. Perez CA, Gardner P, Glasgow GP. Radiotherapy quality assurance in clinical trials. Int J Radiat Oncol Biol Phys 1984;10 (suppl 1):119-25
54. Ferez CA, Purdy JA, Harms W, Gerber R, Matthews J, Grigsby PW et al. Design of a fully integrated three-dimensional computed tomography simulator and preliminary clinical evaluation. Int J Radiat Oncol Biol Phys 1994;30:887-97
55. Ferez CA, Kobeissi B, Smith BD, Fox S, Grigsby PW, Purdy JA et al. Cost accounting in radiation oncology: a computer-based model for reimbursement. Int J Radiat Oncol Biol Phys 1993; 25:895-906
56. Peters LJ. Through a glass darkly: predicting the future of radiation oncology. Int J Radiat Oncol Biol Phys 1995;31: 219-25
57. Pettersson F, Swedenborg J. Atherosclerotic occlusive disease after radiation for pelvic malignancies. Acta Chir Scand 1990; 156:367-71
58. Read G. Estimating the cost of radiotherapy Clin Oncol 1994; 6:35-9
59. Roman DD, Sperduto PW. Neuropsychological effects of cranial radiation: current knowledge and future directions. Int J Radiat Oncol Biol Phys 1995;31:983-98
60. Rutigliano MJ, Lunsford LD, Kondziolka D, Strauss MJ, Khanna V, Green M. The cost effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of solitary metastatic brain tumors. Neurosurgery 1995;37:445-53
61. Sack H, Nosbuesch H, Stuetzer H. Radiotherapy of prostate carcinoma: results of treatment and complications. Radiother Oncol 1987;10:7-15
62. Schmitt G, Glaeser L, Kotsch E. Advantages and disadvan-tages of a 5.7 MeV linear accelerator compared to a 60 Co-unit. Strahlentherapie 1978;154:257-60
63. Shrieve DC, Tarbell NJ, Alexander E, Kooy HM, Black PM, Dunbar S et al. Stereotactic radiotherapy: a technique for dose optimization and escalation for intracranial tumors. Acta Neurochir Suppl 1994;62:118-23
64. Simpson JR, Rich KM, Drzymala RE, Wasserman TH, Klein EE, Michaletz-Lorenz M et al. Stereotactic external beam irradiation using a linear accelerator: the Washington University experience. Mo Med 1995;92:188-92
65. Smith TJ, Hillner BE, Desch CE. Efficacy and cost-effectiveness of cancer treatment: rational allocation of resources based on decision analysis. JNCI 1993;85:1460-74
66. Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Making 1993;13:322-38
67. Sperduto PW, Hall WA. Radiosurgery, cost-effectiveness, gold standards, the scientific method, cavalier cow-boys, and the cost of hope. Int J Radiat Oncol Biol Phys 1996;36:511-3
68. Suit H, du Bois W. The importance of optimal treatment planning in radiation therapy. Int J Radiat Oncol Biol Phys 1991; 21:1471-8
69. Syndikus I, Tait D, Ashley S, Jannoun L. Long-term follow-up of young children with brain tumors after irradiation. Int J Radiat Oncol Biol Phys 1994;30:781 -7
70. Vijayakumar S, Chen GT. Implementation of three dimensional conformal radiation therapy: prospects, opportunities, and challenges. Int J Radiat Oncol Biol Phys 1995;33:979-83
71. Zierhut D, Flentje M, Adolph J, Erdmann J, Raue F, Wannenmacher M. External radiotherapy of pituitary adenomas Int J Radiat Oncol Biol Phys 1995;33:307-14